CNTN5 and plasma cell myeloma: To compare CAR-mediated T cell cytotoxicity towards myeloma cells, we produced T cells engineered with otherwise identical CAR constructs incorporating either Nb1, Nb2, or the tandem along with untransduced T (UT) lymphocytes (Figs. 1a, 6a, and Supplementary Fig. 6a).